Related Experiment Video
Updated: Jun 18, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
Hypermethylation-mediated partial transcriptional silencing of DAP-kinase gene in bladder cancer
Ranbir Chander Sobti1, Kianoosh MalekZadeh, Mohsen Nikbakht
1Department of Biotechnology, Panjab University, Chandigarh, India.
Abstract:
Death-associated protein kinase (DAP-kinase) is a novel serine/threonine kinase whose expression is required for interferon-gamma-induced apoptosis. This study evaluated the methylation pattern and its impact on the expression of the DAP-kinase gene in transitional cell carcinoma of the bladder as hypermethylation is one of the earliest and most frequent alterations leading to cancer. The frequency of hypermethylation of the gene promoter was 37.8%. On correlation with clinicopathological features, methylation was seen mostly in superficial tumours in the group aged > 60 years (42.9 vs 33.3% of those
Insights
Hypermethylation of the Death-associated protein kinase (DAP-kinase) gene promoter is common in bladder cancer, particularly in smokers over 60. This epigenetic change reduces DAP-kinase expression, increasing bladder cancer risk and potentially serving as a prognostic indicator.
Area of Science:
- Cancer Biology
- Epigenetics
- Molecular Oncology
Background:
- Death-associated protein kinase (DAP-kinase) is a serine/threonine kinase crucial for interferon-gamma-induced apoptosis.
- Hypermethylation of gene promoters is an early and frequent event in cancer development.
- Transitional cell carcinoma of the bladder is the focus of this study regarding DAP-kinase gene alterations.
Purpose of the Study:
- To investigate the methylation pattern of the DAP-kinase gene in bladder cancer.
- To assess the impact of DAP-kinase gene promoter methylation on its expression.
- To correlate DAP-kinase methylation with clinicopathological features and bladder cancer risk.
Main Methods:
- Analysis of DAP-kinase gene promoter methylation frequency in bladder tumors.
- Correlation of methylation status with patient age, smoking habits, and tumor stage.
- Quantification of DAP-kinase mRNA expression levels in relation to methylation.
- Statistical analysis to determine the risk and odds ratios associated with methylation.
Main Results:
- Hypermethylation of the DAP-kinase gene promoter was observed in 37.8% of bladder tumors.
- Methylation was more frequent in superficial tumors, in patients over 60, and in smokers.
- Carrying methylated DAP-kinase increased bladder cancer risk 6.70-fold, with elevated risk in smokers.
- Gene promoter methylation significantly decreased DAP-kinase mRNA expression by 27.68%.
Conclusions:
- DAP-kinase gene promoter hypermethylation is a significant event in bladder cancer development.
- Reduced DAP-kinase expression due to methylation may contribute to malignant transformation.
- DAP-kinase methylation serves as a potential prognostic indicator for bladder cancer progression.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation